Cargando…

Discovery of Polyphenolic Natural Products as SARS-CoV-2 M(pro) Inhibitors for COVID-19

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has forced the development of direct-acting antiviral drugs due to the coronavirus disease 2019 (COVID-19) pandemic. The main protease of SARS-CoV-2 is a crucial enzyme that breaks down polyproteins synthesized from the viral RNA, maki...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krüger, Nadine, Kronenberger, Thales, Xie, Hang, Rocha, Cheila, Pöhlmann, Stefan, Su, Haixia, Xu, Yechun, Laufer, Stefan A., Pillaiyar, Thanigaimalai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959258/ https://www.ncbi.nlm.nih.gov/pubmed/37259339 http://dx.doi.org/10.3390/ph16020190

Ejemplares similares

COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease
por: Kronenberger, Thales, et al.
Publicado: (2023)

Inhibitor induced conformational changes in SARS-COV-2 papain-like protease
por: Ferreira, Glaucio Monteiro, et al.
Publicado: (2022)

Recent discovery and development of inhibitors targeting coronaviruses
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2020)

Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2017)

A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2020)

Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID‐19
por: Manickam, Manoj, et al.
Publicado: (2021)

Anticancer Drug Conjugates Incorporating Estrogen Receptor Ligands
por: Zlotos, Darius P., et al.
Publicado: (2022)

An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2016)

Investigations on SARS-CoV-2 Susceptibility of Domestic and Wild Animals Using Primary Cell Culture Models Derived from the Upper and Lower Respiratory Tract
por: Färber, Iris, et al.
Publicado: (2022)

Polyvalent Nano-Lectin Potently Neutralizes SARS-CoV-2 by Targeting Glycans on the Viral Spike Protein
por: Budhadev, Darshita, et al.
Publicado: (2023)

The Upper Respiratory Tract of Felids Is Highly Susceptible to SARS-CoV-2 Infection
por: Krüger, Nadine, et al.
Publicado: (2021)

Reaction of indoles with aromatic fluoromethyl ketones: an efficient synthesis of trifluoromethyl(indolyl)phenylmethanols using K(2)CO(3)/n-Bu(4)PBr in water
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2020)

Drug discovery and development targeting the life cycle of SARS-CoV-2
por: Su, Haixia, et al.
Publicado: (2021)

Multi-omics for COVID-19: driving development of therapeutics and vaccines
por: Guo, Mengyu, et al.
Publicado: (2023)

In silico screening-based discovery of novel covalent inhibitors of the SARS-CoV-2 3CL protease
por: Xiong, Muya, et al.
Publicado: (2022)

The recent outbreaks of human coronaviruses: A medicinal chemistry perspective
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2020)

Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. Viruses 2022, 14, 177
por: Jäger, Niklas, et al.
Publicado: (2022)

Discrepancy in interactions and conformational dynamics of pregnane X receptor (PXR) bound to an agonist and a novel competitive antagonist
por: Rashidian, Azam, et al.
Publicado: (2022)

Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice
por: Hess, Cornelius, et al.
Publicado: (2016)

Cell Type-Specific Anti-Viral Effects of Novel SARS-CoV-2 Main Protease Inhibitors
por: Geiger, Nina, et al.
Publicado: (2023)

Editorial: Natural polyphenols and metabolic syndrome
por: Zhang, Juntao, et al.
Publicado: (2023)

Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1
por: Sidarovich, Anzhalika, et al.
Publicado: (2022)

Research Strategies in the Study of the Pro-Oxidant Nature of Polyphenol Nutraceuticals
por: Babich, Harvey, et al.
Publicado: (2011)

Iodine-catalyzed electrophilic substitution of indoles: Synthesis of (un)symmetrical diindolylmethanes with a quaternary carbon center
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2021)

Molecular Modeling Applied to Nucleic Acid-Based Molecule Development
por: Krüger, Arne, et al.
Publicado: (2018)

Discovery of PL(pro) and M(pro) Inhibitors for SARS-CoV-2
por: Puhl, Ana C., et al.
Publicado: (2023)

Discovery of novel inhibitors against main protease (Mpro) of SARS-CoV-2 via virtual screening and biochemical evaluation
por: Guo, Sheng, et al.
Publicado: (2021)

SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies
por: Arora, Prerna, et al.
Publicado: (2022)

Drug repurposing and computational modeling for discovery of inhibitors of the main protease (M(pro)) of SARS-CoV-2
por: Silva, José Rogério A., et al.
Publicado: (2021)

Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety
por: Konno, Sho, et al.
Publicado: (2013)

Design, synthesis and biological evaluation of peptidomimetic benzothiazolyl ketones as 3CL(pro) inhibitors against SARS-CoV-2
por: Yang, Hanxi, et al.
Publicado: (2023)

Discovery of a Novel Class of Covalent Dual Inhibitors Targeting the Protein Kinases BMX and BTK
por: Forster, Michael, et al.
Publicado: (2020)

Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studies
por: Thanigaimalai, Pillaiyar, et al.
Publicado: (2013)

Discovery of Diverse Natural Products as Inhibitors of SARS-CoV-2 M(pro) Protease through Virtual Screening
por: Rubio-Martínez, Jaime, et al.
Publicado: (2021)

Efficient discovery of potential inhibitors for SARS-CoV-2 3C-like protease from herbal extracts using a native MS-based affinity-selection method
por: Zhu, Dafu, et al.
Publicado: (2022)

Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins
por: Plegge, Teresa, et al.
Publicado: (2019)

Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: Structure–activity relationship study
por: Thanigaimalai, Pillaiyar, et al.
Publicado: (2013)

6-(Ar)Alkylamino-Substituted Uracil Derivatives: Lipid Mimetics with Potent Activity at the Orphan G Protein-Coupled Receptor 84 (GPR84)
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2018)

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
por: Hoffmann, Markus, et al.
Publicado: (2022)

Dietary Polyphenols as Natural Inhibitors of α-Amylase and α-Glucosidase
por: Ćorković, Ina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v2m3l444mbk0oliu7o5a8mej2a